Advanced Multi-Modal Wearable Sensing for the Prediction of Pre-Term Labor
1 other identifier
observational
91
1 country
1
Brief Summary
Percent agreement of vital signs monitoring between the experimental sensor and standard of care monitoring
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 15, 2020
CompletedFirst Posted
Study publicly available on registry
April 27, 2020
CompletedStudy Start
First participant enrolled
January 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2021
CompletedMarch 3, 2022
March 1, 2022
11 months
April 15, 2020
March 2, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Device comparison to standard monitoring
The primary outcome measure is concordance of FHR tracing assessments from Rogers sensor recordings with those obtained from the current standard of care electronic fetal monitoring systems.
2 years
Study Arms (2)
Subjects seen in hospital
Subjects will be recruited from Prentice Women's Hospital inpatient antepartum and labor and delivery services, and the outpatient Obstetrics and Gynecology practice, located within Galter tower with the assistance of staff.
Home Study subjects
Subjects will be prescreened by an IRB approved staff and recruited from Prentice Women's Hospital's Department of Obstetrics and Gynecology.
Interventions
vital signs monitoring during maternal non-stress testing or in the home setting
Eligibility Criteria
Pregnant women
You may not qualify if:
- Women who refuse to signed the informed consent form
- Maternal age under 18 years old
- Multiple pregnancy
- Known major fetal malformation or chromosomal abnormality
- Medical or obstetric problem that would preclude the use of abdominal electrodes
- Inability to consent to this study due to medical illness, diminished intellectual capacity, or language barrier
- Women using pacemakers
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Northwestern University
Chicago, Illinois, 60611, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Shuai Xu, MD
Northwestern University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 15, 2020
First Posted
April 27, 2020
Study Start
January 1, 2021
Primary Completion
December 1, 2021
Study Completion
December 1, 2021
Last Updated
March 3, 2022
Record last verified: 2022-03